Course of Platelet Activation and Platelet-Leukocyte Interaction in Cerebrovascular Ischemia
- 1 September 2006
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (9) , 2283-2287
- https://doi.org/10.1161/01.str.0000236638.75591.61
Abstract
Platelet activation plays a crucial role in the pathophysiology of cerebral ischemia. The aim of this study was to investigate the contribution of platelet activation and leukocyte-platelet interactions to the disease. One hundred thirty-five patients with transient ischemic attack (TIA) or stroke were enrolled in this single-center study. They underwent cranial computer tomography within 24 hours of clinical onset and after 3 months, and systemic venous blood samples were drawn. Platelet activation (CD62P expression), leukocyte activation (L-selectin expression), and the appearance of platelet-specific antigens on leukocytes as an index of platelet-leukocyte aggregation were measured by flow cytometric techniques in the acute state and at 3-month follow-up. Patients with a completed stroke or TIA had significantly increased circulating platelet-leukocyte aggregates, increased P-selectin expression on platelets, and decreased L-selectin expression in the acute state compared with the control group (healthy volunteers). No differences in regard to the tested activation markers could be detected between patients with stroke or TIA in the acute phase of the disease. However, platelet and leukocyte activations were normalized after 3 months in patients with TIA, whereas leukocyte activation (reduced L-selectin expression) remained in stroke patients. In patients with TIA and completed stroke, platelet and leukocyte activation is substantially enhanced in the acute phase of the disease. The sustained leukocyte activation observed in stroke but not in TIA patients at 3-month follow up might play a pathophysiological role in the course of the disease.Keywords
This publication has 27 references indexed in Scilit:
- Platelet-Leukocyte Interaction and Platelet Activation in Acute Stroke With and Without Preceding InfectionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Platelet Degranulation Is Associated With Progression of Intima-Media Thickness of the Common Carotid Artery in Patients With Diabetes Mellitus Type 2Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Platelet–Leukocyte–Endothelial Cell Interactions after Middle Cerebral Artery Occlusion and ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2004
- Platelet degranulation and monocyte–platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attackBritish Journal of Haematology, 2004
- Leukocyte Count as an Independent Predictor of Recurrent Ischemic EventsStroke, 2004
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationThe Journal of Experimental Medicine, 2002
- Inflammation, Hemostatic Markers, and Antithrombotic Agents in Relation to Long-Term Risk of New Cardiovascular Events in First-Ever Ischemic Stroke PatientsStroke, 2002
- In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia majorBritish Journal of Haematology, 1997
- Activated platelets signal chemokine synthesis by human monocytes.Journal of Clinical Investigation, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993